Physiological Mechanisms Inherent to Diabetes Involved in the Development of Dementia: Alzheimer’s Disease

Physiological Mechanisms Inherent to Diabetes Involved in the Development of Dementia: Alzheimer’s Disease

Type 2 diabetes mellitus (T2D) is a metabolic disease reaching pandemic levels worldwide. In parallel, Alzheimer’s disease (AD) and vascular dementia (VaD) are the two leading causes of dementia in an increasingly long-living Western society. Numerous epidemiological studies support the role of T2D...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Himan Mohamed-Mohamed, Victoria García-Morales, Encarnación María Sánchez Lara, Anabel González-Acedo, Teresa Pardo-Moreno, María Isabel Tovar-Gálvez, Lucía Melguizo-Rodríguez, Juan José Ramos-Rodríguez
Format:	Artykuł
Język:	English
Wydane:	MDPI AG 2023-10-01
Seria:	Neurology International
Hasła przedmiotowe:	Alzheimer’s disease dementia vascular dementia diabetes insulin neurodegeneration
Dostęp online:	https://www.mdpi.com/2035-8377/15/4/79

Podobne zapisy

Total and regional fat‐to‐muscle mass ratio and risks of incident all‐cause dementia, Alzheimer's disease, and vascular dementia
od: Wenxiu Wang, i wsp.
Wydane: (2022-10-01)

Plasma Markers of Alzheimer's Disease Pathology, Neuronal Injury, and Astrocytic Activation and MRI Load of Vascular Pathology and Neurodegeneration: The SMART‐MR Study
od: Emma L. Twait, i wsp.
Wydane: (2024-02-01)

Air pollution: a latent key driving force of dementia
od: Mahdiyeh Mohammadzadeh, i wsp.
Wydane: (2024-09-01)

Alzheimer's Disease - A Comprehensive Review
od: Kinga Woźniak, i wsp.
Wydane: (2024-02-01)

Is Montreal Cognitive Assessment a valuable test for the differentiation of Alzheimer's disease, frontotemporal dementia, dementia with Lewy body, and vascular dementia?
od: Fatemeh Afrashteh, i wsp.
Wydane: (2024-08-01)

ALZHEIMER (AD) - A MULTIFACTORIAL NEURODEGENERATIVE DISEASE - A COHORT STUDY
od: Paula Denisa Saragea, i wsp.
Wydane: (2024-09-01)

Cerebrospinal Fluid EV Concentration and Size Are Altered in Alzheimer’s Disease and Dementia with Lewy Bodies
od: Antonio Longobardi, i wsp.
Wydane: (2022-01-01)

Genetic evidence for causal association between migraine and dementia: a mendelian randomization study
od: Qiuyi Chen, i wsp.
Wydane: (2024-07-01)

Risk of dementia in primary aldosteronism compared with essential hypertension: a nationwide cohort study
od: Namki Hong, i wsp.
Wydane: (2023-08-01)

Addition of inflammation-related biomarkers to the CAIDE model for risk prediction of all-cause dementia, Alzheimer’s disease and vascular dementia in a prospective study
od: Kira Trares, i wsp.
Wydane: (2024-04-01)

Plasma metabolic profiles predict future dementia and dementia subtypes: a prospective analysis of 274,160 participants
od: Yi-Xuan Qiang, i wsp.
Wydane: (2024-01-01)

Risk of Dementia after Exposure to Contrast Media: A Nationwide, Population-Based Cohort Study
od: Tung-Min Yu, i wsp.
Wydane: (2022-08-01)

Neuropsychological differential diagnosis of Alzheimer’s disease and vascular dementia: a systematic review with meta-regressions
od: Leo Sokolovič, i wsp.
Wydane: (2023-11-01)

Tramadol use and incident dementia in older adults with musculoskeletal pain: a population-based retrospective cohort study
od: Si Nae Oh, i wsp.
Wydane: (2024-10-01)

Mechanisms of ozone-induced neurotoxicity in the development and progression of dementia: a brief review
od: Luis A. Marin-Castañeda, i wsp.
Wydane: (2024-10-01)

Specification curve analysis to identify heterogeneity in risk factors for dementia: findings from the UK Biobank
od: Renhao Luo, i wsp.
Wydane: (2024-05-01)

Coffee and tea are unlikely to be risk factors or preventers of Alzheimer's disease or vascular dementia
od: Josef Finsterer
Wydane: (2025-02-01)

Neuroimaging techniques for diagnosing Alzheimer’s disease and cerebrovascular diseases with cognitive impairment
od: I. V. Litvinenko, i wsp.
Wydane: (2019-06-01)

Comparative Assessments of PET and ASL MR Perfusion in the Evaluation of Early Dementia
od: Savyasachi Jain, i wsp.
Wydane: (2025-02-01)

Lipidomics profiling reveals distinct patterns of plasma sphingolipid alterations in Alzheimer’s disease and vascular dementia
od: Xin Ying Chua, i wsp.
Wydane: (2023-12-01)

Dementia: epidemiology, clinical picture, diagnosis, approaches to therapy
od: Irina Sergeyevna Preobrazhenskaya
Wydane: (2013-12-01)

Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives
od: Teresa Pardo-Moreno, i wsp.
Wydane: (2022-05-01)

Use of methylphenidate in alzheimer’s dementia: Effect on apathy
od: R. Borralho, i wsp.
Wydane: (2021-04-01)

Dementia incidence varied by anticancer drugs and molecular targeted therapy in a population-based cohort study
od: Eun Hye Lee, i wsp.
Wydane: (2024-07-01)

Investigating the nexus of metabolic syndrome, serum uric acid, and dementia risk: a prospective cohort study
od: Tara SR Chen, i wsp.
Wydane: (2024-03-01)

Thirty Risk Factors for Alzheimer’s Disease Unified by a Common Neuroimmune–Neuroinflammation Mechanism
od: Donald F. Weaver
Wydane: (2023-12-01)

Mental Health Literacy and Dementia
od: Hannah Carr, i wsp.
Wydane: (2021-05-01)

Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Vascular Dementia
od: Arianna Romani, i wsp.
Wydane: (2020-05-01)

Coffee and tea consumption and dementia risk: The role of sex and vascular comorbidities
od: Kuan-Chu Hou, i wsp.
Wydane: (2025-02-01)

Illustrated Neuropathologic Diagnosis of Alzheimer’s Disease
od: Nicholas Doher, i wsp.
Wydane: (2023-07-01)

Reply to “Coffee and tea consumption and dementia risk: The role of sex and vascular comorbidities”
od: Kuan-Chu Hou, i wsp.
Wydane: (2025-02-01)

Reply to “Concerns about methodology and findings in coffee and tea consumption and dementia research”
od: Kuan-Chu Hou, i wsp.
Wydane: (2025-02-01)

Reduced dementia incidence after varicella zoster vaccination in Wales 2013–2020
od: Christian Schnier, i wsp.
Wydane: (2022-01-01)

Risk of dementia in survivors of active tuberculosis in Korea: A nationwide cohort study
od: Yohwan Yeo, i wsp.
Wydane: (2024-02-01)

Alterations of amino acids in older adults with Alzheimer’s Disease and Vascular Dementia
od: Xin Ma, i wsp.
Wydane: (2025-01-01)

Association between Atrial Fibrillation and Risk of Alzheimer’s Disease and Vascular Dementia: A Systematic Review and Meta-analysis
od: Yi Zheng, i wsp.
Wydane: (2024-12-01)

Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development
od: Desh Deepak Singh, i wsp.
Wydane: (2022-11-01)

A comprehensive evaluation on the associations between hearing and vision impairments and risk of all-cause and cause-specific dementia: results from cohort study, meta-analysis and Mendelian randomization study
od: Fan Jiang, i wsp.
Wydane: (2024-11-01)

Infectious agents as a risk factor for Alzheimer’s disease
od: S. V. Vorobyev, i wsp.
Wydane: (2020-03-01)

Advancing Alzheimer’s care: a novel therapy with lecanemab
od: Advait Teli, i wsp.
Wydane: (2023-11-01)